Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [3]
- ELISA [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN394446 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-N-Myc (And STAT) Interactor (NMI) (AA 1-101) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-101
- Isotype
- IgG
- Antibody clone number
- 9D8
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references New genetic associations detected in a host response study to hepatitis B vaccine.
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
The effects of common genetic variants in oncogenes on ovarian cancer survival.
Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M
Genes and immunity 2010 Apr;11(3):232-8
Genes and immunity 2010 Apr;11(3):232-8
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Høgdall C, Blaakaer J, Ovarian Cancer Association Consortium., Easton DF, Ponder BA, Jacobs IJ, Menon U, Whittemore AS, Krüger-Kjaer S, Pearce CL, Pharoah PD, Gayther SA
British journal of cancer 2009 Mar 24;100(6):993-1001
British journal of cancer 2009 Mar 24;100(6):993-1001
Evaluating new candidate SNPs as low penetrance risk factors in sporadic breast cancer: a two-stage Spanish case-control study.
Vega A, Salas A, Milne RL, Carracedo B, Ribas G, Ruibal A, de León AC, González-Hernández A, Benítez J, Carracedo A
Gynecologic oncology 2009 Jan;112(1):210-4
Gynecologic oncology 2009 Jan;112(1):210-4
Nmi (N-Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth.
Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS
International journal of cancer 2009 Aug 1;125(3):556-64
International journal of cancer 2009 Aug 1;125(3):556-64
The effects of common genetic variants in oncogenes on ovarian cancer survival.
Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, Whittemore AS, Pearce CL, Pharoah PD, Song H
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 15;14(18):5833-9
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 15;14(18):5833-9
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC